DNA Brands, Inc.
DNAX · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $339 | $149 | $149 | $297 |
| - Cash | $0 | $0 | $1 | $1 |
| + Debt | $3,113 | $3,060 | $3,010 | $2,960 |
| Enterprise Value | $3,453 | $3,208 | $3,157 | $3,255 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$80 | -$50 | -$51 | -$63 |
| % Margin | – | – | – | – |
| Net Income | -$138 | -$156 | -$107 | -$120 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0 | -0 | -0 |
| % Growth | 100% | 0% | 50% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |